These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 1502972
1. The impact of prior substance abuse on treatment outcome for bulimia nervosa. Strasser TJ, Pike KM, Walsh BT. Addict Behav; 1992; 17(4):387-95. PubMed ID: 1502972 [Abstract] [Full Text] [Related]
2. Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study. McCann UD, Agras WS. Am J Psychiatry; 1990 Nov; 147(11):1509-13. PubMed ID: 2221164 [Abstract] [Full Text] [Related]
3. Medication and psychotherapy in the treatment of bulimia nervosa. Walsh BT, Wilson GT, Loeb KL, Devlin MJ, Pike KM, Roose SP, Fleiss J, Waternaux C. Am J Psychiatry; 1997 Apr; 154(4):523-31. PubMed ID: 9090340 [Abstract] [Full Text] [Related]
4. Long-term outcome of antidepressant treatment for bulimia nervosa. Walsh BT, Hadigan CM, Devlin MJ, Gladis M, Roose SP. Am J Psychiatry; 1991 Sep; 148(9):1206-12. PubMed ID: 1882999 [Abstract] [Full Text] [Related]
6. Lifetime anxiety disorders in women with bulimia nervosa. Bulik CM, Sullivan PF, Carter FA, Joyce PR. Compr Psychiatry; 1996 Mar; 37(5):368-74. PubMed ID: 8879912 [Abstract] [Full Text] [Related]
7. Treatment of bulimia with fenfluramine and desipramine. Blouin AG, Blouin JH, Perez EL, Bushnik T, Zuro C, Mulder E. J Clin Psychopharmacol; 1988 Aug; 8(4):261-9. PubMed ID: 3062043 [Abstract] [Full Text] [Related]
8. Characteristics of patients with bulimia only, bulimia with affective disorder, and bulimia with substance abuse problems. Hatsukami D, Mitchell JE, Eckert ED, Pyle R. Addict Behav; 1986 Aug; 11(4):399-406. PubMed ID: 3812049 [Abstract] [Full Text] [Related]
9. Lifetime substance abuse, family history of alcohol abuse/dependence and novelty seeking in eating disorders: comparison study of eating disorder subgroups. Krug I, Pinheiro AP, Bulik C, Jiménez-Murcia S, Granero R, Penelo E, Masuet C, Agüera Z, Fernández-Aranda F. Psychiatry Clin Neurosci; 2009 Feb; 63(1):82-7. PubMed ID: 19154214 [Abstract] [Full Text] [Related]
10. Substance use among women with eating disorders. Wiederman MW, Pryor T. Int J Eat Disord; 1996 Sep; 20(2):163-8. PubMed ID: 8863068 [Abstract] [Full Text] [Related]
16. Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa. Leitenberg H, Rosen JC, Wolf J, Vara LS, Detzer MJ, Srebnik D. Behav Res Ther; 1994 Jan; 32(1):37-45. PubMed ID: 8135721 [Abstract] [Full Text] [Related]
17. One-year follow-up of psychosocial and pharmacologic treatments for bulimia nervosa. Agras WS, Rossiter EM, Arnow B, Telch CF, Raeburn SD, Bruce B, Koran LM. J Clin Psychiatry; 1994 May; 55(5):179-83. PubMed ID: 8071266 [Abstract] [Full Text] [Related]
19. Prescription diuretic abuse in patients with bulimia nervosa. Pomeroy C, Mitchell JE, Seim HC, Seppala M. J Fam Pract; 1988 Nov; 27(5):493-6. PubMed ID: 3193066 [Abstract] [Full Text] [Related]
20. Comparing cognitive behavioural therapy for eating disorders integrated with behavioural weight loss therapy to cognitive behavioural therapy-enhanced alone in overweight or obese people with bulimia nervosa or binge eating disorder: study protocol for a randomised controlled trial. Palavras MA, Hay P, Touyz S, Sainsbury A, da Luz F, Swinbourne J, Estella NM, Claudino A. Trials; 2015 Dec 18; 16():578. PubMed ID: 26683478 [Abstract] [Full Text] [Related] Page: [Next] [New Search]